IHS Chemical Week

Regions :: India/Pakistan

Dr. Reddy's and Fujifilm call off JV for generic drugs in Japan, to explore opportunities in APIs

7:59 AM MDT | June 3, 2013 | Deepti Ramesh

Dr. Reddy’s Laboratories (Hyderabad, India) and Fujifilm (Tokyo) have decided to terminate their previously announced agreement for an exclusive partnership in the generic drugs business in the Japanese market via a joint venture in Japan, the companies announced today. Dr. Reddy’s and Fujifilm signed an memorandum of understanding (MOU) in July 2011 to establish a jv in Japan for manufacturing finished generic drugs for the Japanese market. It was agreed that Fujifilm would hold a 51% stake in the jv, and Dr. Reddy’s would hold the rest. The...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa